US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 8.030
  • +0.040+0.50%
Trading Dec 19 10:43 ET
549.07MMarket Cap-1.40P/E (TTM)

Phathom Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-99.20%-63.57M
-218.56%-70.72M
-73.99%-69.02M
6.11%-137.58M
-6.72%-43.8M
8.86%-31.91M
13.67%-22.2M
11.37%-39.67M
1.30%-146.53M
0.54%-41.04M
Net income from continuing operations
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
Depreciation and amortization
57.85%191K
60.16%197K
46.58%214K
-7.26%575K
10.12%185K
-30.86%121K
-17.45%123K
14.06%146K
19.00%620K
24.44%168K
Other non cash items
91.44%14.32M
112.88%14.81M
105.94%15.01M
52.63%32.06M
41.13%10.33M
1.20%7.48M
60.47%6.96M
272.51%7.29M
288.35%21M
398.50%7.32M
Change In working capital
157.42%1.39M
-114.13%-626K
57.03%-7.02M
-350.90%-13.64M
593.43%676K
-189.57%-2.41M
-70.13%4.43M
-36.71%-16.34M
119.91%5.44M
98.80%-137K
-Change in receivables
---10.18M
---7M
---2.24M
---1.64M
---1.64M
--0
--0
--0
--0
----
-Change in inventory
-276.58%-418K
--268K
---416K
---9.44M
---9.33M
---111K
--0
--0
--0
--0
-Change in prepaid assets
112.42%519K
-282.12%-2.75M
108.69%447K
-333.71%-8.07M
93.88%-254K
-569.66%-4.18M
-73.90%1.51M
-17.31%-5.14M
-407.44%-1.86M
-61.43%-4.15M
-Change in payables and accrued expense
116.15%11.42M
206.69%8.81M
56.84%-4.85M
-12.44%6.7M
148.23%9.8M
190.80%5.28M
-69.33%2.87M
-50.49%-11.25M
127.12%7.65M
143.90%3.95M
-Change in other current assets
----
----
----
-1,081.36%-1.39M
205,500.00%2.06M
----
----
----
-158.13%-118K
-99.38%1K
-Change in other working capital
-8.33%44K
-8.16%45K
-10.00%45K
181.51%194K
-30.88%47K
469.23%48K
115.56%49K
127.27%50K
-342.86%-238K
195.65%68K
Cash from discontinued investing activities
Operating cash flow
-99.20%-63.57M
-218.56%-70.72M
-73.99%-69.02M
6.11%-137.58M
-6.72%-43.8M
8.86%-31.91M
13.67%-22.2M
11.37%-39.67M
1.30%-146.53M
0.54%-41.04M
Investing cash flow
Cash flow from continuing investing activities
95.31%-44K
-666.67%-46K
81.31%-40K
-56.96%-1.63M
-15.29%-475K
-600.75%-939K
98.60%-6K
-219.40%-214K
-217.38%-1.04M
-312.00%-412K
Net PPE purchase and sale
95.31%-44K
-666.67%-46K
81.31%-40K
-56.96%-1.63M
-15.29%-475K
-600.75%-939K
98.60%-6K
-219.40%-214K
-217.38%-1.04M
-312.00%-412K
Cash from discontinued investing activities
Investing cash flow
95.31%-44K
-666.67%-46K
81.31%-40K
-56.96%-1.63M
-15.29%-475K
-600.75%-939K
98.60%-6K
-219.40%-214K
-217.38%-1.04M
-312.00%-412K
Financing cash flow
Cash flow from continuing financing activities
938,800.00%122.06M
-82.49%24.77M
-29.65%9.9M
206.21%367.58M
211.99M
-99.95%13K
48.25%141.5M
14.07M
168.50%120.04M
0
Net issuance payments of debt
--0
--24.75M
--9.9M
--39.32M
--39.32M
--0
--0
--0
--0
----
Net common stock issuance
--121.78M
--0
--0
532.07%155.46M
--0
--0
--141.39M
--14.07M
--24.6M
--0
Proceeds from stock option exercised by employees
2,069.23%282K
----
----
--124K
--0
--13K
----
----
--0
--0
Net other financing activities
----
----
----
80.91%172.68M
----
----
----
----
--95.45M
--0
Cash from discontinued financing activities
Financing cash flow
938,800.00%122.06M
-82.49%24.77M
-29.65%9.9M
206.21%367.58M
--211.99M
-99.95%13K
48.25%141.5M
--14.07M
168.50%120.04M
--0
Net cash flow
Beginning cash position
11.92%279.1M
149.92%325.1M
146.49%384.26M
-15.01%155.89M
9.73%216.54M
19.95%249.38M
-6.14%130.08M
-15.01%155.89M
-36.20%183.42M
-12.14%197.34M
Current changes in cash
277.95%58.44M
-138.56%-46M
-129.20%-59.16M
929.55%228.37M
504.61%167.72M
-211.16%-32.84M
72.14%119.3M
42.42%-25.81M
73.55%-27.53M
-0.62%-41.45M
End cash Position
55.88%337.54M
11.92%279.1M
149.92%325.1M
146.49%384.26M
146.49%384.26M
9.73%216.54M
19.95%249.38M
-6.14%130.08M
-15.01%155.89M
-15.01%155.89M
Free cash flow
-93.64%-63.62M
-218.68%-70.77M
-73.16%-69.06M
5.66%-139.21M
-6.80%-44.27M
6.53%-32.85M
15.06%-22.21M
11.02%-39.88M
0.82%-147.57M
-0.22%-41.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -99.20%-63.57M-218.56%-70.72M-73.99%-69.02M6.11%-137.58M-6.72%-43.8M8.86%-31.91M13.67%-22.2M11.37%-39.67M1.30%-146.53M0.54%-41.04M
Net income from continuing operations -97.90%-85.58M-123.23%-91.45M-119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M
Depreciation and amortization 57.85%191K60.16%197K46.58%214K-7.26%575K10.12%185K-30.86%121K-17.45%123K14.06%146K19.00%620K24.44%168K
Other non cash items 91.44%14.32M112.88%14.81M105.94%15.01M52.63%32.06M41.13%10.33M1.20%7.48M60.47%6.96M272.51%7.29M288.35%21M398.50%7.32M
Change In working capital 157.42%1.39M-114.13%-626K57.03%-7.02M-350.90%-13.64M593.43%676K-189.57%-2.41M-70.13%4.43M-36.71%-16.34M119.91%5.44M98.80%-137K
-Change in receivables ---10.18M---7M---2.24M---1.64M---1.64M--0--0--0--0----
-Change in inventory -276.58%-418K--268K---416K---9.44M---9.33M---111K--0--0--0--0
-Change in prepaid assets 112.42%519K-282.12%-2.75M108.69%447K-333.71%-8.07M93.88%-254K-569.66%-4.18M-73.90%1.51M-17.31%-5.14M-407.44%-1.86M-61.43%-4.15M
-Change in payables and accrued expense 116.15%11.42M206.69%8.81M56.84%-4.85M-12.44%6.7M148.23%9.8M190.80%5.28M-69.33%2.87M-50.49%-11.25M127.12%7.65M143.90%3.95M
-Change in other current assets -------------1,081.36%-1.39M205,500.00%2.06M-------------158.13%-118K-99.38%1K
-Change in other working capital -8.33%44K-8.16%45K-10.00%45K181.51%194K-30.88%47K469.23%48K115.56%49K127.27%50K-342.86%-238K195.65%68K
Cash from discontinued investing activities
Operating cash flow -99.20%-63.57M-218.56%-70.72M-73.99%-69.02M6.11%-137.58M-6.72%-43.8M8.86%-31.91M13.67%-22.2M11.37%-39.67M1.30%-146.53M0.54%-41.04M
Investing cash flow
Cash flow from continuing investing activities 95.31%-44K-666.67%-46K81.31%-40K-56.96%-1.63M-15.29%-475K-600.75%-939K98.60%-6K-219.40%-214K-217.38%-1.04M-312.00%-412K
Net PPE purchase and sale 95.31%-44K-666.67%-46K81.31%-40K-56.96%-1.63M-15.29%-475K-600.75%-939K98.60%-6K-219.40%-214K-217.38%-1.04M-312.00%-412K
Cash from discontinued investing activities
Investing cash flow 95.31%-44K-666.67%-46K81.31%-40K-56.96%-1.63M-15.29%-475K-600.75%-939K98.60%-6K-219.40%-214K-217.38%-1.04M-312.00%-412K
Financing cash flow
Cash flow from continuing financing activities 938,800.00%122.06M-82.49%24.77M-29.65%9.9M206.21%367.58M211.99M-99.95%13K48.25%141.5M14.07M168.50%120.04M0
Net issuance payments of debt --0--24.75M--9.9M--39.32M--39.32M--0--0--0--0----
Net common stock issuance --121.78M--0--0532.07%155.46M--0--0--141.39M--14.07M--24.6M--0
Proceeds from stock option exercised by employees 2,069.23%282K----------124K--0--13K----------0--0
Net other financing activities ------------80.91%172.68M------------------95.45M--0
Cash from discontinued financing activities
Financing cash flow 938,800.00%122.06M-82.49%24.77M-29.65%9.9M206.21%367.58M--211.99M-99.95%13K48.25%141.5M--14.07M168.50%120.04M--0
Net cash flow
Beginning cash position 11.92%279.1M149.92%325.1M146.49%384.26M-15.01%155.89M9.73%216.54M19.95%249.38M-6.14%130.08M-15.01%155.89M-36.20%183.42M-12.14%197.34M
Current changes in cash 277.95%58.44M-138.56%-46M-129.20%-59.16M929.55%228.37M504.61%167.72M-211.16%-32.84M72.14%119.3M42.42%-25.81M73.55%-27.53M-0.62%-41.45M
End cash Position 55.88%337.54M11.92%279.1M149.92%325.1M146.49%384.26M146.49%384.26M9.73%216.54M19.95%249.38M-6.14%130.08M-15.01%155.89M-15.01%155.89M
Free cash flow -93.64%-63.62M-218.68%-70.77M-73.16%-69.06M5.66%-139.21M-6.80%-44.27M6.53%-32.85M15.06%-22.21M11.02%-39.88M0.82%-147.57M-0.22%-41.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+2.61%
Amazon
AMZN
+1.70%
Petroleo Brasileiro SA Petrobras
PBR
+1.52%
Meta Platforms
META
+1.16%
Tesla
TSLA
+1.15%

Unlock the Full List